This brand name is authorized in Israel, United States
The drug EXONDYS 51 contains one active pharmaceutical ingredient (API):
|
1
Eteplirsen
UNII AIW6036FAS - ETEPLIRSEN
|
|
Eteplirsen is designed to bind to exon 51 of dystrophin pre-mRNA, resulting in exclusion of this exon during mRNA processing in patients with genetic mutations that are amenable to exon 51 skipping. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| EXONDYS 51 Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 8237, 8401 |
| Country: US | FDA, National Drug Code | Identifier(s): 60923-284, 60923-363 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
